Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 20/20 | 0.84 |
| ▸ | EGFR | P00533 | 5/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.72 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.53 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5635572 | 1.00 | ERBB2 (0.84) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5568357 | 0.93 | ERBB2 (0.87) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5636299 | 0.93 | ERBB2 (0.87) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5635982 | 0.93 | ERBB2 (0.87) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5636356 | 0.93 | ERBB2 (0.84) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5573245 | 0.93 | ERBB2 (0.84) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5637173 | 0.92 | ERBB2 (0.85) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5570232 | 0.91 | ERBB2 (0.84) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5636961 | 0.91 | ERBB2 (1.00) | ERBB2EGFRKCNH2ERBB3ERBB4 | |
| SCHEMBL5572349 | 0.91 | ERBB2 (1.00) | ERBB2EGFRKCNH2ERBB3ERBB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756088-A1 | QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES | AstraZeneca AB (SE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005118572-A1 | QUINAZOLINE DERIVATIVES AS ERBB RECEPTOR TYROSINE KINASES | ASTRAZENECA AB (SE) | 2005-12-15 | — | — | WO | disclosed |